Edition:
United Kingdom

Essex Bio-Technology Ltd (1061.HK)

1061.HK on Hong Kong Stock

7.60HKD
24 May 2019
Change (% chg)

HK$0.31 (+4.25%)
Prev Close
HK$7.29
Open
HK$7.38
Day's High
HK$7.65
Day's Low
HK$7.38
Volume
695,000
Avg. Vol
482,056
52-wk High
HK$8.63
52-wk Low
HK$3.79

Latest Key Developments (Source: Significant Developments)

Essex Bio-Technology Posts Profit For Year Of HK$231.1 Million
Monday, 11 Mar 2019 

March 11 (Reuters) - Essex Bio-Technology Ltd <1061.HK>::PROPOSE A FINAL DIVIDEND OF HK$0.033 PER ORDINARY SHARE.FY PROFIT FOR YEAR HK$231.1 MILLION VERSUS HK$ 167.3 MILLION.FY TURNOVER HK$1.18 BILLION VERSUS HK$899.6 MILLION.  Full Article

Essex Bio-Technology Says Unit Obtained Approval From State Drug Administration For A Product
Wednesday, 22 Aug 2018 

Aug 22 (Reuters) - Essex Bio-Technology Ltd <1061.HK>::GETS APPROVAL TO COMMERCIALISE PRESERVATIVE-FREE SINGLE-DOSE SODIUM HYALURONATE EYE DROPS IN CHINA.SAYS UNIT OBTAINED APPROVAL FROM STATE DRUG ADMINISTRATION FOR PRODUCT.  Full Article

Essex Bio-Technology Says Unit to Make Investment In Chengdu Shanggong
Wednesday, 18 Jul 2018 

July 18 (Reuters) - Essex Bio-Technology Ltd <1061.HK>::ZHUHAI ESSEX SHALL MAKE AN INVESTMENT OF RMB20 MILLION AS CAPITAL CONTRIBUTION IN CHENGDU SHANGGONG.  Full Article

Essex Bio-Technology's Unit Gets Approval For Commercialisation Of Eye Drops In China
Tuesday, 17 Jul 2018 

July 17 (Reuters) - Essex Bio-Technology Ltd <1061.HK>::UNIT GETS APPROVAL FROM STATE DRUG ADMINISTRATION FOR COMMERCIALISATION OF SINGLE-DOSE LEVOFLOXACIN EYE DROPS IN CHINA.  Full Article

Essex bio-technology terminates proposed KDR programme​
Monday, 16 Oct 2017 

Oct 16 (Reuters) - Essex Bio-technology Ltd <1061.HK>::Terminated proposed KDR programme​.‍KDR programme termination to not have adverse effect on co's financial position​.  Full Article